123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice

Схожі ресурси

• Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
  за авторством: Kersemans, V, та інші
  Опубліковано: (2004)
• 123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
  за авторством: Cornelissen, B, та інші
  Опубліковано: (2004)
• In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.
  за авторством: Kersemans, V, та інші
  Опубліковано: (2004)
• In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT
  за авторством: Kersemans, V, та інші
  Опубліковано: (2004)
• In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
  за авторством: Cornelissen, B, та інші
  Опубліковано: (2005)